Investor Relations

The primary objective of our Investor Relations activities is to communicate with the financial community, especially private as well as institutional investors and analysts, in an open and timely manner. Our focus is on conducting a correct, comprehensive and fair dialogue.
IR EVENT  
August 23, 2010  
pdf Commerzbank Sector Conference, Frankfurt (649 kb)pdf (267 kb)> More meetings
PRESENTATION OF FINANCIAL RESULTS    
July 29, 2010

pdf Results 2nd Quarter / Half-Year Financial Report (2.3 MB)
> Results of prior quarters
Dr. Michael Becker
"Merck is an innovative pharmaceutical and chemical company with a portfolio of complementary business dynamics that will drive the quality growth of the Group going forward."
Dr. Michael Becker

IR NEWS

07/29/2010
Q2/2010: Merck KGaA Profit After Tax Jumps 70% to EUR 187 Million

UPCOMING DATES

10/26/2010
Publication of business results for Q3 2010 (Conference Call)